KDM6B and neoplasm: Inflammatory cytokines such as TNF-α and IL-6 have been shown to upregulate histone demethylases, including Jmjd3 (KDM6B), which affects the expression of genes, leading to stem-like, therapy-resistant tumour phenotypes [120].